 BOTHELL, Wash., Nov. 09, 2022 GLOBE NEWSWIRE -- Athira Pharma, Inc. NASDAQ: ATHA, a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that members of Athiras management team will participate in the Stifel 2022 Healthcare Conference taking place Nov. 15-16, 2022 in New York City. Members of management will participate in a fireside chat on Wednesday, Nov. 16, 2022 at 4:45 p.m. EST. 